These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18573134)

  • 1. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter.
    Neade T; Uribarri J
    Semin Dial; 2008; 21(4):331-7. PubMed ID: 18573134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular disease and chronic renal failure: new insights.
    Nanayakkara PW; Gaillard CA
    Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of chronic kidney disease for dietary treatment in cardiovascular disease.
    Packard DP; Milton JE; Shuler LA; Short RA; Tuttle KR
    J Ren Nutr; 2006 Jul; 16(3):259-68. PubMed ID: 16825032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6 Suppl 3():S4-12. PubMed ID: 16340933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular risk factors and renal failure].
    Madore F
    Med Sci (Paris); 2004 Dec; 20(12):1100-3. PubMed ID: 15581463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
    Tunuguntla A; Yerra L
    Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hsCRP, sICAM-1 and TAFI in hemodialysis patients: linking inflammation and hypofibrinolysis to cardiovascular events.
    Gad MZ; El-Mesallamy HO; Sanad EF
    Kidney Blood Press Res; 2008; 31(6):391-7. PubMed ID: 19052466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
    Stenvinkel P
    Nephrol Ther; 2006 Jul; 2(3):111-9. PubMed ID: 16890135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.